This trial is active, not recruiting.

Conditions acute pain, pain, postoperative
Treatment elbow fracture fixation
Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Start date January 2009
End date June 2014
Trial size 200 participants
Trial identifier NCT02210429, 2014-15849


We hypothesize that patients who receive a supraclavicular block via Angiocath, placed intra-operatively and dosed post-operatively following neurologic examination, will have lower pain scores, lower use of intravenous morphine equivalents in the post-anesthesia care unit, and lower rates of intervention for post-operative nausea and vomiting. We also hypothesize that patients receiving this nerve block had the same rates of nerve damage as the patients who did not receive a block and that there will be no demonstrable safety concerns with this block.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification safety/efficacy study
Intervention model factorial assignment
Masking open label
Primary purpose treatment
(Active Comparator)
elbow fracture fixation
(Active Comparator)
elbow fracture fixation
(Active Comparator)
elbow fracture fixation
(Active Comparator)
elbow fracture fixation

Primary Outcomes

Post-operative opioid use
time frame: 24 hours

Secondary Outcomes

Anti-emetic drug use
time frame: 24 hours
Incidence of nerve damage or compartment syndrome
time frame: 1 month
Pain Score
time frame: 24 hours

Eligibility Criteria

Male or female participants up to 17 years old.

Inclusion Criteria: - Age under 18 - Undergoing supracondylar fracture fixation in operating room Exclusion Criteria: - Incomplete or inaccessable chart data

Additional Information

Official title Supraclavicular Blocks for Post-Operative Pain Control in Supracondylar Fracture Fixation, a Retrospective Analysis of Single Shot Catheter Techniques
Principal investigator Santhanam Suresh, MD
Trial information was received from ClinicalTrials.gov and was last updated in July 2015.
Information provided to ClinicalTrials.gov by Ann & Robert H Lurie Children's Hospital of Chicago.